Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH Study

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502 · see citing works

Role of Insulin Resistance in Human Disease

Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154 · see citing works

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504 · see citing works

The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men

Lakka, H.-M. (2002) · JAMA · doi:10.1001/jama.288.21.2709 · Cited by 5,033 · see citing works

Banting lecture 1988. Role of insulin resistance in human disease.

Reaven, G. (1988) · Diabetes · doi:10.2337/diabetes.37.12.1595 · Cited by 3,801 · see citing works

Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.

Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L., & Spiegelman, B. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117936 · Cited by 3,543 · see citing works

A step-by-step approach to using the SAS system for factor analysis and structural equation modeling

(1995) · Choice Reviews Online · doi:10.5860/choice.33-0366 · Cited by 3,357 · see citing works

C-Reactive Protein in Healthy Subjects: Associations With Obesity, Insulin Resistance, and Endothelial Dysfunction: A Potential Role for Cytokines Originating From Adipose Tissue?

Yudkin, J. S., Stehouwer, C. D. A., Emeis, J. J., & Coppack, S. W. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.4.972 · Cited by 2,465 · see citing works

Plasma Concentration of Interleukin-6 and the Risk of Future Myocardial Infarction Among Apparently Healthy Men

Ridker, P. M., Rifai, N., Stampfer, M. J., & Hennekens, C. H. (2000) · Circulation · doi:10.1161/01.cir.101.15.1767 · Cited by 2,429 · see citing works

Chronic Subclinical Inflammation as Part of the Insulin Resistance Syndrome

Festa, A., D’Agostino, R., Howard, G., Mykkänen, L. M., Tracy, R. P., & Haffner, S. M. (2000) · Circulation · doi:10.1161/01.cir.102.1.42 · Cited by 2,363 · see citing works

Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor-α,in Vivo1

Mohamed‐Ali, V., Goodrick, S., Rawesh, A., Katz, D. R., Miles, J. M., Yudkin, J. S., Klein, S., & Coppack, S. W. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4450 · Cited by 2,012 · see citing works

Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance

Kern, P. A., Ranganathan, S., Li, C., Wood, L., & Ranganathan, G. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.5.e745 · Cited by 1,883 · see citing works

Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?

Yudkin, J. S., Kumari, M., Humphries, S. E., & Mohamed-Ali, V. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00463-3 · Cited by 1,775 · see citing works

The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase

Kern, P. A., Saghizadeh, M., Ong, J. M., Bosch, R. J., Deem, R., & Simsolo, R. B. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117899 · Cited by 1,305 · see citing works

How good a marker is insulin level for insulin resistance?

Laakso, M. (1993) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116768 · Cited by 726 · see citing works

Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor- , in Vivo

Mohamed-Ali, V. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.12.4196 · Cited by 717 · see citing works

Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study

MEADE, T. (1993) · The Lancet · doi:10.1016/0140-6736(93)92062-x · Cited by 711 · see citing works

Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis

Juhan-Vague, I., Alessi, M., & Vague, P. (1991) · Diabetologia · doi:10.1007/bf00403280 · Cited by 566 · see citing works

Risk Variable Clustering in the Insulin Resistance Syndrome: The Framingham Offspring Study

Meigs, J. B., D’Agostino, R. B., Wilson, P. W. F., Cupples, L. A., Nathan, D. M., & Singer, D. E. (1997) · Diabetes · doi:10.2337/diacare.46.10.1594 · Cited by 525 · see citing works

Evaluation of Simple Indices of Insulin Sensitivity and Insulin Secretion for Use in Epidemioiogic Studies

Hanson, R. L., Pratley, R. E., Bogardus, C., Narayan, K. M. V., Roumain, J. M. L., Imperatore, G., Fagot-Campagna, A., Pettitt, D. J., Bennett, P. H., & Knowler, W. C. (2000) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010187 · Cited by 463 · see citing works

Clustering of Procoagulation, Inflammation, and Fibrinolysis Variables with Metabolic Factors in Insulin Resistance Syndrome

Sakkinen, P. A., WAHL, P. W., Cushman, M., Lewis, M. R., & Tracy, R. P. (2000) · American Journal of Epidemiology · doi:10.1093/aje/152.10.897 · Cited by 420 · see citing works

Invited Commentary: Insulin Resistance Syndrome? Syndrome X? Multiple Metabolic Syndrome? A Syndrome At All? Factor Analysis Reveals Patterns in the Fabric of Correlated Metabolic Risk Factors

Meigs, J. B. (2000) · American Journal of Epidemiology · doi:10.1093/aje/152.10.908 · Cited by 397 · see citing works

Insulin and Risk of Cardiovascular Disease

Ruige, J. B., Assendelft, W. J., Dekker, J. M., Kostense, P. J., Heine, R. J., & Bouter, L. M. (1998) · Circulation · doi:10.1161/01.cir.97.10.996 · Cited by 393 · see citing works

Endothelial Dysfunction: Cause of the Insulin Resistance Syndrome

Pinkney, J. H., Stehouwer, C. D. A., Coppack, S. W., & Yudkin, J. S. (1997) · Diabetes · doi:10.2337/diab.46.2.s9 · Cited by 350 · see citing works

Insulin Resistance Syndrome Predicts the Risk of Coronary Heart Disease and Stroke in Healthy Middle-Aged Men

Pyörälä, M., Miettinen, H., Halonen, P. M., Laakso, M., & Pyörälà, K. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.2.538 · Cited by 349 · see citing works

Involvement of the hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris. The ECAT Angina Pectoris Study Group.

Juhan-Vague, I., Thompson, S. G., & Jespersen, J. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.12.1865 · Cited by 326 · see citing works

Insulin Resistance Syndrome Predicts Coronary Heart Disease Events in Elderly Nondiabetic Men

Lempiäinen, P., Mykkänen, L., Pyörälä, K., Laakso, M., & Kuusisto, J. (1999) · Circulation · doi:10.1161/01.cir.100.2.123 · Cited by 293 · see citing works

Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes

Hermans, M. P., Lévy, J., Morris, R. J., & Turner, R. C. (1999) · Diabetologia · doi:10.1007/s001250051215 · Cited by 260 · see citing works

Elevated plasma interleukin-6 levels in patients with acute myocardial infarction

Miyao, Y., Yasue, H., Ogawa, H., Misumi, I., 増田, 武., Sakamoto, T., & Morita, E. (1993) · American Heart Journal · doi:10.1016/0002-8703(93)90526-f · Cited by 205 · see citing works

Plasma Thrombin-Activatable Fibrinolysis Inhibitor Antigen Concentration and Genotype in Relation to Myocardial Infarction in the North and South of Europe

Juhan-Vague, I., Morange, P., Aubert, H., Henry, M., Aillaud, M. F., Alessi, M., Samnegård, A., Hawe, E., Yudkin, J. S., Margaglione, M., et al. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000015445.22243.f4 · Cited by 146 · see citing works

Insulin Resistance Syndrome Predicts Coronary Heart Disease Events in Elderly Type 2 Diabetic Men

Kuusisto, J., Lempiäinen, P. A., Mykkänen, L. M., & Laakso, M. (2001) · Diabetes Care · doi:10.2337/diacare.24.9.1629 · Cited by 109 · see citing works

Consumption of black and green tea has no effect on inflammation, haemostasis and endothelial markers in smoking healthy individuals

de Maat, M., Pijl, H., Kluft, C., & Princen, H. (2000) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601084 · Cited by 101 · see citing works

Interleukins 6 and 8 as mediators of acute phase response in acute myocardial infarction.

Pannitteri, G., Marino, B., Campa, P. P., Martucci, R., Testa, U., & Peschle, C. (1997) · American Journal of Cardiology · doi:10.1016/s0002-9149(97)00434-7 · Cited by 77 · see citing works

Concentrations of proinsulin like molecules predict coronary heart disease risk independently of insulin: prospective data from the Caerphilly Study

Yudkin, J. S., May, M., Elwood, P. C., YARNELL, J. W. G., Greenwood, R., & Smith, G. D. (2002) · Diabetologia · doi:10.1007/s00125-001-0756-7 · Cited by 69 · see citing works

High proinsulin concentration precedes acute myocardial infarction in a nondiabetic population

Lindahl, B., Dinesen, B., Eliasson, M., Røder, M. E., Jansson, J., Huhtasaari, F., & Hallmans, G. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90138-5 · Cited by 61 · see citing works

Association of proinsulin-like molecules with lipids and fibrinogen in non-diabetic subjects ? evidence against a modulating role for insulin

Mohamed‐Ali, V., Gould, M., Gillies, S., Goubet, S., Yudkin, J. S., & Haines, A. (1995) · Diabetologia · doi:10.1007/bf00402183 · Cited by 50 · see citing works

The Relationship of Concentrations of Insulin and Proinsulin-Like Molecules With Coronary Heart Disease Prevalence and Incidence: A study of two ethnic groups

Yudkin, J., Denver, A., Mohamed-ali, V., Ramaiya, K., Nagi, D., Goubet, S., Mclarty, D., & Swai, A. (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1093 · Cited by 43 · see citing works

RE: “CLUSTERING OF PROCOAGULATION, INFLAMMATION, AND FIBRINOLYSIS VARIABLES WITH METABOLIC FACTORS IN INSULIN RESISTANCE SYNDROME”

Hu, F. B. (2001) · American Journal of Epidemiology · doi:10.1093/aje/153.7.717 · Cited by 9 · see citing works

Inflammation, Atherosclerosis, and Coronary Artery Disease

Hansson, G. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043430 · Cited by 8,773 · see citing works

Adipose Tissue, Inflammation, and Cardiovascular Disease

Berg, A. H., & Scherer, P. E. (2005) · Circulation Research · doi:10.1161/01.res.0000163635.62927.34 · Cited by 2,113 · see citing works

INFLAMMATION AND ATHEROSCLEROSIS

Hansson, G. K., Robertson, A.-K. L., & Söderberg‐Nauclér, C. (2006) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100100 · Cited by 1,049 · see citing works

Periodontal infections cause changes in traditional and novel cardiovascular risk factors: results from a randomized controlled clinical trial

D'Aiuto, F., Parkar, M., Nibali, L., Suvan, J., Lessem, J., & Tonetti, M. S. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.06.018 · Cited by 332 · see citing works

The CardioMetabolic Health Alliance

Sperling, L. S., Mechanick, J. I., Neeland, I. J., Herrick, C. J., Després, J.-P., Ndumele, C. E., Vijayaraghavan, K., Handelsman, Y., Puckrein, G. A., Araneta, M. R. G., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.06.1328 · Cited by 294 · see citing works

Human C-reactive protein and the metabolic syndrome

Devaraj, S., Singh, U. S., & Jialal, I. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32832ac03e · Cited by 291 · see citing works

Inflammation in sleep apnea: An update

Unnikrishnan, D. C., Jun, J. C., & Polotsky, V. Y. (2014) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-014-9304-x · Cited by 225 · see citing works

A score of low-grade inflammation and risk of mortality: prospective findings from the Moli-sani study

Bonaccio, M., Castelnuovo, A. F. D., Pounis, G., Curtis, A. D., Costanzo, S., Persichillo, M., Cerletti, C., Donati, M. B., de Gaetano, G., & Iacoviello, L. (2016) · Haematologica · doi:10.3324/haematol.2016.144055 · Cited by 200 · see citing works

Hypercoagulability in the metabolic syndrome

Nieuwdorp, M., Stroes, E. S. G., Meijers, J. C. M., & Buller, H. R. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.10.003 · Cited by 190 · see citing works

Hypercoagulation and thrombophilia in liver disease

Northup, P. G., Sundaram, V., Fallon, M. B., Reddy, K. R., Balogun, R. A., Sanyal, A. J., Anstee, Q. M., Hoffman, M., Ikura, Y., & CALDWELL, S. H. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02772.x · Cited by 184 · see citing works

An exercise intervention without weight loss decreases circulating interleukin-6 in lean and obese men with and without type 2 diabetes mellitus

Dekker, M. J., Lee, S., HUDSON, R. W., Kilpatrick, K., Graham, T. E., Ross, R., & Robinson, L. E. (2007) · Metabolism · doi:10.1016/j.metabol.2006.10.015 · Cited by 176 · see citing works

Relation Between the Metabolic Syndrome and Ischemic Stroke or Transient Ischemic Attack

Koren‐Morag, N., Goldbourt, U., & Tanné, D. (2005) · Stroke · doi:10.1161/01.str.0000169945.75911.33 · Cited by 175 · see citing works

Central Adiposity, Systemic Inflammation, and the Metabolic Syndrome

Elks, C. M., & Francis, J. (2010) · Current Hypertension Reports · doi:10.1007/s11906-010-0096-4 · Cited by 166 · see citing works

Metabolic stress in insulin's target cells leads to ROS accumulation – A hypothetical common pathway causing insulin resistance

Eriksson, J. W. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.06.044 · Cited by 165 · see citing works

Delayed response and lack of habituation in plasma interleukin-6 to acute mental stress in men

von Känel, R., Kudielka, B. M., Preckel, D., Hanebuth, D., & Fischer, J. E. (2006) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2005.03.013 · Cited by 158 · see citing works

Venous thromboembolism a manifestation of the metabolic syndrome

Ay, C., Tengler, T., Vormittag, R., Simanek, R., Dorda, W., Vukovich, T., & Pabinger, I. (2007) · Haematologica · doi:10.3324/haematol.10828 · Cited by 155 · see citing works

Genome-Wide Association Study of the Metabolic Syndrome in UK Biobank

Lind, L. (2019) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2019.0070 · Cited by 137 · see citing works

Effects of Periodontal Therapy on Systemic Markers of Inflammation in Patients With Metabolic Syndrome: A Controlled Clinical Trial

López, N., Quintero, A., Casanova, P. A., Ibieta, C. I., Bælum, V., & López, R. (2011) · Journal of Periodontology · doi:10.1902/jop.2011.110227 · Cited by 134 · see citing works

Soluble urokinase plasminogen activator receptor is a marker of dysmetabolism in HIV‐infected patients receiving highly active antiretroviral therapy

Andersen, O., Eugen‐Olsen, J., Kofoed, K., Iversen, J., & Haugaard, S. B. (2007) · Journal of Medical Virology · doi:10.1002/jmv.21114 · Cited by 131 · see citing works

Inflammation in Coronary Artery Disease

Christodoulidis, G., Vittorio, T. J., Fudim, M., Lerakis, S., & Kosmas, C. E. (2014) · Cardiology in Review · doi:10.1097/crd.0000000000000006 · Cited by 127 · see citing works

Hypertension and dyslipidaemia in obesity and insulin resistance: Pathophysiology, impact on atherosclerotic disease and pharmacotherapy

Chapman, M. J., & Sposito, A. C. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.10.004 · Cited by 123 · see citing works

Adipose tissue, inflammation and cardiovascular disease

Ikeoka, D., Mader, J. K., & Pieber, T. R. (2010) · Revista da Associação Médica Brasileira · doi:10.1590/s0104-42302010000100026 · Cited by 109 · see citing works

Serum adiponectin and resistin levels in major depressive disorder

Lehto, S. M., Huotari, A., NISKANEN, L. K., Tolmunen, T., Koivumaa-Honkanen, H. T., Honkalampi, K. M., Ruotsalainen, H. J., Herzig, K., Viinamäki, H. T., & Hintikka, J. J. (2009) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2009.01463.x · Cited by 103 · see citing works

Nontraditional cardiovascular risk factors in pediatric metabolic syndrome

Retnakaran, R. R., Zinman, B., Connelly, P. W., Harris, S. B., & Hanley, A. J. (2006) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2005.08.025 · Cited by 103 · see citing works

Serum levels of interleukin 6, C-reactive protein, vascular cell adhesion molecule 1, and monocyte chemotactic protein 1 in relation to insulin resistance and glucose intolerance—the Chennai Urban Rural Epidemiology Study (CURES)

Deepa, R., Velmurugan, K., Arvind, K., Pillarisetti, S., Sientay, C., Saxena, U., & Mohan, V. (2006) · Metabolism · doi:10.1016/j.metabol.2006.05.008 · Cited by 101 · see citing works

Fat distribution and storage: how much, where, and how?

Weiss, R. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0125 · Cited by 102 · see citing works

ApoB/apoA1 is an effective predictor of coronary heart disease risk in overweight and obesity

Lü, M., Lu, Q., Zhang, Y., & Tian, G. (2011) · Journal of Biomedical Research · doi:10.1016/s1674-8301(11)60036-5 · Cited by 97 · see citing works

Cytokine and growth factor profiling in patients with the metabolic syndrome

Mirhafez, S. R., Pasdar, A., Avan, A., Esmaily, H., Moezzi, A., Mohebati, M., Meshkat, Z., Mehrad‐Majd, H., Eslami, S., Rahimi, H. R., et al. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515001038 · Cited by 90 · see citing works

Metabolic Syndrome

Ravaglia, G., Forti, P., Maioli, F., Bastagli, L., Chiappelli, M., Montesi, F., Bolondi, L., & Patterson, C. (2006) · Diabetes Care · doi:10.2337/dc06-0282 · Cited by 88 · see citing works

Sleep-Disordered Breathing and Gestational Diabetes Mellitus

Luque-Fernández, M. Á., Bain, P. A., Gelaye, B., Redline, S. S., & Williams, M. A. (2013) · Diabetes Care · doi:10.2337/dc13-0778 · Cited by 83 · see citing works

C-Reactive Protein Is Elevated 30 Years After Eclamptic Pregnancy

Hubel, C. A., Powers, R. W., Snaedal, S., Gammill, H. S., Ness, R. B., Roberts, J. M., & Arngrı́msson, R. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.109934 · Cited by 79 · see citing works

Comprehensive analysis of circulating adipokines and hsCRP association with cardiovascular disease risk factors and metabolic syndrome in Arabs

Abu‐Farha, M., Behbehani, K., & Elkum, N. B. (2014) · Cardiovascular Diabetology · doi:10.1186/1475-2840-13-76 · Cited by 78 · see citing works

Should we give thromboprophylaxis to patients with liver cirrhosis and coagulopathy?

Senzolo, M., Sartori, M. T., & Lisman, T. (2009) · HPB · doi:10.1111/j.1477-2574.2009.00079.x · Cited by 77 · see citing works

Circulating angiopoietin-like protein 8 (betatrophin) association with HsCRP and metabolic syndrome

Abu‐Farha, M., Abubaker, J. A., Al‐Khairi, I., Cherian, P., Noronha, F., Kavalakatt, S., Khadir, A., Behbehani, K., Alarouj, M., Bennakhi, A., et al. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0346-0 · Cited by 76 · see citing works

Insulin resistance and the metabolic syndrome—or the pitfalls of epidemiology

Yudkin, J. S. (2007) · Diabetologia · doi:10.1007/s00125-007-0711-3 · Cited by 75 · see citing works

C-reactive Protein Is Associated With Prevalence of the Metabolic Syndrome, Hypertension, and Diabetes Mellitus in US Adults

Mazidi, M., Toth, P. P., & Banach, M. (2017) · Angiology · doi:10.1177/0003319717729288 · Cited by 75 · see citing works

Metabolic syndrome in patients with acute myocardial infarction is associated with increased infarct size and in-hospital complications

Clavijo, L., Pinto, T. L., Kuchulakanti, P. K., Torguson, R., Chu, W. W., Satler, L. F., Kent, K. M., Suddath, W. O., Pichard, A. D., & Waksman, R. (2006) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2005.10.007 · Cited by 75 · see citing works

Studies of Gene Variants Related to Inflammation, Oxidative Stress, Dyslipidemia, and Obesity: Implications for a Nutrigenetic Approach

Curti, M. L. R., Jacob, P., Borges, M. C., Rogero, M. M., & Ferreira, S. R. G. (2011) · Journal of Obesity · doi:10.1155/2011/497401 · Cited by 73 · see citing works

Capacidade dos biomarcadores inflamatórios em predizer a síndrome metabólica: Inflammation biomarkers capacity in predicting the metabolic syndrome

Volp, A. C. P., Alfenas, R. D. C. G., Costa, N. M. B., Minim, V. P. R., Stringheta, P. C., & Bressan, J. (2008) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302008000300015 · Cited by 70 · see citing works

Role of C-Reactive Protein in Contributing to Increased Cardiovascular Risk in Metabolic Syndrome

Devaraj, S., Valleggi, S., Siegel, D., & Jialal, I. (2010) · Current Atherosclerosis Reports · doi:10.1007/s11883-010-0098-3 · Cited by 70 · see citing works

EPCR Ser219Gly: Elevated sEPCR, prothrombin F1+2, risk for coronary heart disease, and increased sEPCR shedding in vitro

Ireland, H., Konstantoulas, C. J., Cooper, J. A., Hawe, E., Humphries, S. E., Mather, H. M., Goodall, A. H., Hogwood, J., Juhan-Vague, I., & Yudkin, J. S. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.02.028 · Cited by 69 · see citing works

Fibroblast growth factor-19 levels in type 2 diabetic patients with metabolic syndrome.

Barutçuoğlu, B., Başol, G., Çakır, Y., Çetinkalp, Ş., Parıldar, Z., Kabaroğlu, C., Ozmen, D., MUTAF, I., & Bayındır, O. (2011) · PubMed · Cited by 68 · see citing works

Metabolic Syndrome and Cardiometabolic Risk Factors

Papakonstantinou, E., Lambadiari, V., Dimitriadis, G., & Zampelas, A. (2014) · Current Vascular Pharmacology · doi:10.2174/15701611113116660176 · Cited by 67 · see citing works

Do inflammation and procoagulation biomarkers contribute to the metabolic syndrome cluster?

Kraja, A. T., Province, M. A., Arnett, D. K., Wagenknecht, L. E., Tang, W., Hopkins, P. N., Djoussé, L., & Borecki, I. B. (2007) · Nutrition & Metabolism · doi:10.1186/1743-7075-4-28 · Cited by 67 · see citing works

Targeting the Human Genome–Microbiome Axis for Drug Discovery: Inspirations from Global Systems Biology and Traditional Chinese Medicine

Zhao, L., Nicholson, J. K., Lü, A., Wang, Z., Tang, H., Holmes, E. C., Shen, J., Zhang, X., Li, J. V., & Lindon, J. C. (2012) · Journal of Proteome Research · doi:10.1021/pr3001628 · Cited by 66 · see citing works

Immunosenescence in atherosclerosis: A role for chronic viral infections

Talepoor, A. G., & Doroudchi, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.945016 · Cited by 64 · see citing works

Association of Cholecystectomy with Metabolic Syndrome in a Chinese Population

Shen, C., Wu, X., Xu, C., Yu, C., Chen, P., & Li, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088189 · Cited by 64 · see citing works

Inflammation and conjugated linoleic acid: mechanisms of action and implications for human health

Zulet, M. A., Marti, A., Parra, M. D., & Martínez, J. A. (2005) · Journal of Physiology and Biochemistry · doi:10.1007/bf03168454 · Cited by 62 · see citing works

Comparison of anti-inflammatory effect of atorvastatin with rosuvastatin in patients of acute coronary syndrome

Khurana, S., Gupta, S., Bhalla, H. L., Nandwani, S., & Gupta, V. (2015) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.162011 · Cited by 61 · see citing works

HIV, Inflammation, and Calcium in Atherosclerosis

Shrestha, S., Irvin, M. R., Grünfeld, C., & Arnett, D. K. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.302191 · Cited by 61 · see citing works

Prevalence and correlates of metabolic syndrome (MS) in older adults

Cankurtaran, M., Halil, M. G., Doğu, B. B., Dağlı, N., Oyan, B., & Arıoğul, S. (2005) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2005.05.004 · Cited by 59 · see citing works

Role of Akt/protein kinase B in the activity of transcriptional coactivator p300

Chen, J., Halappanavar, S. S., St‐Germain, J. R., Tsang, B. K., & Li, Q. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4103-9 · Cited by 55 · see citing works

Rescue of cardiac leptin receptors indb/dbmice prevents myocardial triglyceride accumulation

Hall, M. E., Maready, M. W., Hall, J. E., & Stec, D. E. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00005.2014 · Cited by 53 · see citing works

Novel Approach to Treat Insulin Resistance, Type 2 Diabetes, and the Metabolic Syndrome: Simultaneous Activation of PPARα, PPARγ, and PPARδ

Evans, J. L., Lin, J., & Goldfine, I. D. (2005) · Current Diabetes Reviews · doi:10.2174/157339905774574365 · Cited by 55 · see citing works

Impact of interleukin 6 −174G>C polymorphism on obesity-related metabolic disorders in people with excess in body weight

Goyenechea, E., Parra, D., & Martínez, J. A. (2007) · Metabolism · doi:10.1016/j.metabol.2007.07.005 · Cited by 54 · see citing works

T Cell–Mediated Inflammation in Adipose Tissue Does Not Cause Insulin Resistance in Hyperlipidemic Mice

Sultan, A., Strodthoff, D., Robertson, A.-K. L., Paulsson‐Berne, G., Fauconnier, J., Parini, P., Rydén, M., Thierry‐Mieg, N., Johansson, M. E., Chibalin, A., et al. (2009) · Circulation Research · doi:10.1161/circresaha.108.190280 · Cited by 50 · see citing works

Whole-body systems approaches for gut microbiota-targeted, preventive healthcare

Zhao, L., & Shen, J. (2010) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2010.02.008 · Cited by 50 · see citing works

Sleep, Appetite, and Obesity—What Is the Link?

Prinz, P. N. (2004) · PLoS Medicine · doi:10.1371/journal.pmed.0010061 · Cited by 47 · see citing works

Adipokine Dysregulation in Turner Syndrome: Comparison of Circulating Interleukin-6 and Leptin Concentrations with Measures of Adiposity and C-Reactive Protein

Ostberg, J. E., Hosseinzadeh‐Attar, M. J., Mohamed‐Ali, V., & Conway, G. S. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1966 · Cited by 47 · see citing works

A Nutrigenomic Inflammation-Related PBMC-Based Approach to Predict the Weight-Loss Regain in Obese Subjects

Goyenechea, E., Parra, D., Crujeiras, A. B., Abete, I., & Martínez, J. A. (2009) · Annals of Nutrition and Metabolism · doi:10.1159/000205319 · Cited by 42 · see citing works

Pathophysiology of metabolic syndrome X and its links to the perinatal period

Das, U. N. (2005) · Nutrition · doi:10.1016/j.nut.2004.11.005 · Cited by 42 · see citing works

Eosinophil Inversely Associates with Type 2 Diabetes and Insulin Resistance in Chinese Adults

Zhū, L., Su, T., Xu, M., Xu, Y., Li, M., Wang, T., Sun, J., Zhang, J., Xu, B., Lu, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067613 · Cited by 41 · see citing works

Pharmacological myeloperoxidase (MPO) inhibition in an obese/hypertensive mouse model attenuates obesity and liver damage, but not cardiac remodeling

Piek, A., Koonen, D. P. Y., Schouten, E., Lindtstedt, E. L., Michaëlsson, E., de Boer, R. A., & Silljé, H. H. W. (2019) · Scientific Reports · doi:10.1038/s41598-019-55263-y · Cited by 41 · see citing works

Blood glucose lowering by means of lifestyle intervention has different effects on adipokines as compared with insulin treatment in subjects with type 2 diabetes

Aas, A., Seljeflot, I., Torjesen, P. A., Diep, L. M., Thorsby, P. M., & Birkeland, K. I. (2006) · Diabetologia · doi:10.1007/s00125-006-0205-8 · Cited by 40 · see citing works

Molecular and signaling mechanisms of atherosclerosis in insulin resistance.

Schwartz, E., & Reaven, P. (2006) · Endocrinology and metabolism clinics of North America (Print) · doi:10.1016/j.ecl.2006.06.005 · Cited by 38 · see citing works

The Metabolic Syndrome in Systemic Lupus Erythematosus

Parker, B., & Bruce, I. N. (2010) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2009.12.004 · Cited by 39 · see citing works

Plasma Sfrp5 levels correlate with determinants of the metabolic syndrome in Chinese adults

Xu, Q., Wang, H., Li, Y., Wang, J., Lai, Y., Gao, L., Lei, L., Yang, G., Liao, X., Xia, F., et al. (2017) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2896 · Cited by 38 · see citing works

Two Major QTLs and Several Others Relate to Factors of Metabolic Syndrome in the Family Blood Pressure Program

Kraja, A. T., Rao, D. C., Weder, A. B., Cooper, R., Curb, J. D., Hanis, C. L., Turner, S. T., de Andrade, M., Hsiung, C. A., Quertermous, T., et al. (2005) · Hypertension · doi:10.1161/01.hyp.0000184249.20016.bb · Cited by 36 · see citing works

Impact of the Metabolic Syndrome on the Clinical Outcome of Patients with Acute ST-Elevation Myocardial Infarction

Lee, M. G., Jeong, M. H., Ahn, Y., Chae, S. C., Hur, S., Hong, T. J., Kim, Y. J., Seong, I. W., Chae, J. K., Rhew, J. Y., et al. (2010) · Journal of Korean Medical Science · doi:10.3346/jkms.2010.25.10.1456 · Cited by 34 · see citing works

Association of IL-6 and CRP gene polymorphisms with obesity and metabolic disorders in children and adolescents

Todendi, P. F., Klinger, E. I., Ferreira, M. B., Reuter, C. P., Burgos, M. S., Possuelo, L. G., & Valim, A. R. D. M. (2015) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765201520140364 · Cited by 32 · see citing works

The metabolic syndrome and the risk of thrombosis

Dentali, F., Romualdi, E., & Ageno, W. (2007) · Haematologica · doi:10.3324/haematol.11243 · Cited by 33 · see citing works

Exercise prior to fat ingestion lowers fasting and postprandial VLDL and decreases adipose tissue IL-6 and GIP receptor mRNA in hypertriacylglycerolemic men.

Dekker, M. J., Graham, T. E., Ooi, T. C., & Robinson, L. E. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.08.004 · Cited by 32 · see citing works

Cognitive‐behavioural stress management does not improve biological cardiovascular risk indicators in women with ischaemic heart disease: a randomized‐controlled trial

Claesson, M., Birgander, L. S., Jansson, J.-H., Lindahl, B., Burell, G. K., Asplund, K., & MATTSSON, C. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01691.x · Cited by 31 · see citing works

Fasting triacylglycerol status, but not polyunsaturated/saturated fatty acid ratio, influences the postprandial response to a series of oral fat tolerance tests

Dekker, M. J., Wright, A. J., Mazurak, V. C., Marangoni, A. G., Rush, J. W. E., Graham, T. E., & Robinson, L. E. (2008) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2008.06.012 · Cited by 30 · see citing works

Long‐term metabolic syndrome is associated with periodontal pockets and alveolar bone loss

Tegelberg, P., Tervonen, T., Knuuttila, M. L. E., Jokelainen, J. J., Keinanen-Kiukaanniemi, S. M., AUVINEN, J. P., & Ylöstalo, P. (2019) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.13154 · Cited by 29 · see citing works

Effect of Weight Gain on Cardiac Autonomic Control During Wakefulness and Sleep

Adachi, T., Kuniyoshi, F. H. S., Calvin, A. D., Singh, P., Romero‐Corral, A., van der Walt, C., Davison, D. E., Bukartyk, J., Konečný, T., Pusalavidyasagar, S. S., et al. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.163147 · Cited by 28 · see citing works

Efeitos antioxidantes do selênio e seu elo com a inflamação e síndrome metabólica

Volp, A. C. P., Bressan, J., Hermsdorff, H. H. M., Zulet, M. Á., & Martínez, J. A. (2010) · Revista de Nutrição · doi:10.1590/s1415-52732010000400009 · Cited by 27 · see citing works

Waist circumference as the predominant contributor to the micro-inflammatory response in the metabolic syndrome: a cross sectional study

Rogowski, O., Shapira, I., Bassat, O. K., Chundadze, T., Finn, T., Berliner, S. A., & Steinvil, A. (2010) · Journal of Inflammation · doi:10.1186/1476-9255-7-35 · Cited by 26 · see citing works

Interactions of serum hsCRP with apoB, apoB/AI ratio and some components of metabolic syndrome amplify the predictive values for coronary artery disease

Rasouli, M., & Kiasari, A. M. (2006) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2006.07.003 · Cited by 26 · see citing works

Geschichte und Definition(en) des metabolischen Syndroms

Markolf Hanefeld, E., Schäper, F., & Ceriello, A. (2007) · Der Internist · doi:10.1007/s00108-006-1786-5 · Cited by 23 · see citing works

Interaction between the C-260T polymorphism of the CD14 gene and the plasma IL-6 concentration on the risk of myocardial infarction: the HIFMECH study

Morange, P., Saut, N., Alessi, M., Frère, C., Hawe, E., Yudkin, J. S., Tremoli, E., Margaglione, M., Minno, G. D., Hamsten, A., et al. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.10.014 · Cited by 25 · see citing works

Biomarkers in metabolic syndrome

Cho, Y. H., Lee, Y., Choi, J. I., Lee, S. R., & Lee, S. Y. (2022) · Advances in clinical chemistry · doi:10.1016/bs.acc.2022.07.003 · Cited by 24 · see citing works

Serum adipokine levels in adults with a history of childhood maltreatment

Lehto, S. M., Elomaa, A.-P., NISKANEN, L. K., Herzig, K., Tolmunen, T., Viinamäki, H. T., Koivumaa-Honkanen, H. T., Huotari, A., Honkalampi, K. M., Valkonen‐Korhonen, M., et al. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.01.016 · Cited by 24 · see citing works

The association between subclinical inflammation and abnormal glucose and lipid metabolisms in normal-weight Korean individuals

Kim, M.-S., Kim, H.-N., & Choi, W.-S. (2018) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2018.06.016 · Cited by 23 · see citing works

The presence of metabolic syndrome is independently associated with elevated serum CD40 ligand and disease severity in patients with symptomatic coronary artery disease

Lee, W.-L., Lee, W., Chen, Y., Liu, T.-J., Liang, K., Ting, C.-T., & Sheu, W. H. (2006) · Metabolism · doi:10.1016/j.metabol.2006.03.013 · Cited by 23 · see citing works

Immune system and atherosclerosis: Hostile or friendly relationship

Razeghian‐Jahromi, I., Akhormeh, A. K., Razmkhah, M., & Zibaeenezhad, M. J. (2022) · International Journal of Immunopathology and Pharmacology · doi:10.1177/03946320221092188 · Cited by 22 · see citing works

Metabolic Syndrome Is Associated With an Increased Risk of Rheumatoid Arthritis: A Prospective Cohort Study Including 369,065 Participants

Luo, P., Wanli, X., Ye, D., Chen, W., Ying, J., Liu, B., Li, J., Sun, X., He, Z., Wen, C., et al. (2024) · The Journal of Rheumatology · doi:10.3899/jrheum.2023-0349 · Cited by 21 · see citing works

The Influence of Coping With Perceived Racism and Stress on Lipid Levels in African Americans

Mwendwa, D. T., Sims, R. C., Madhere, S., Thomas, J., Keen, L., Callender, C. O., & Campbell, A. L. (2011) · Journal of the National Medical Association · doi:10.1016/s0027-9684(15)30385-0 · Cited by 21 · see citing works

Adipocytokines as features of the metabolic syndrome determined using confirmatory factor analysis

Smits, M. M., Woudstra, P., Utzschneider, K. M., Tong, J., Gerchman, F., Faulenbach, M. V., Carr, D. B., Aston‐Mourney, K., Chait, A., Knopp, R. H., et al. (2013) · Annals of Epidemiology · doi:10.1016/j.annepidem.2013.03.001 · Cited by 21 · see citing works

Nontraditional atherosclerotic risk factors and extent of coronary atherosclerosis in patients with combined impaired fasting glucose and impaired glucose tolerance

Surdacki, A., Stochmal, E., Szurkowska, M., Bode‐Böger, S. M., Martens‐Lobenhoffer, J., Stochmal, A., Klecha, A., Kawecka−Jaszcz, K., Dubiel, J. S., Huszno, B., et al. (2006) · Metabolism · doi:10.1016/j.metabol.2006.08.023 · Cited by 20 · see citing works

Elevated Serum Myeloperoxidase Activities are Significantly Associated with the Prevalence of ACS and High LDL-C Levels in CHD Patients

Liu, C., Xie, G., Huang, W., Yang, Y., Li, P., & Tu, Z. (2012) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.9704 · Cited by 19 · see citing works

The role of C‐reactive protein in modern obstetric and gynecological practice

AZIZIA, M. M., Irvine, L. M., COKER, M., & Sanusi, F. A. (2006) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1080/00016340500432614 · Cited by 19 · see citing works

Metabolic syndrome in human immunodeficiency virus-infected patients

Duro, M., Manso, M. C., Barreira, S. V. P., Rebelo, I., Medeiros, R., & Almeida, C. (2018) · International Journal of STD & AIDS · doi:10.1177/0956462418775188 · Cited by 18 · see citing works

Association of WBC count and glucose metabolism among Chinese population aged 40 years and over

Tian, J., Yang, Y., Cheng, Q., Huang, H., Li, R., Jiang, G., Liu, S., Li, X.-Y., & Ning, G. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.05.014 · Cited by 18 · see citing works

Relationships between C-reactive protein, white blood cell count, and insulin resistance in a Chinese population

Xu, Y. H., Zhao, Z., Li, X., Bi, Y., Xu, M., & Ning, G. (2010) · Endocrine · doi:10.1007/s12020-010-9425-2 · Cited by 17 · see citing works

Increased Visceral Adipose Tissue as a Potential Risk Factor in Patients with Embolic Stroke of Undetermined Source (ESUS)

Muuronen, A., Taina, M., Hedman, M., Marttila, J., Kuusisto, J., Onatsu, J., Vanninen, R. L., Jäkälä, P., Sipola, P., & Mustonen, P. E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120598 · Cited by 16 · see citing works

Calculating Insulin Resistance in the Primary Care Setting: Why Should We Worry about Insulin Levels in Euglycemic Patients?

Appel, S. J. (2005) · Journal of the American Academy of Nurse Practitioners · doi:10.1111/j.1745-7599.2005.0052.x · Cited by 16 · see citing works

Serum complement C3 has a stronger association with insulin resistance than high sensitive C-reactive protein in non-diabetic Chinese

Wang, B.-Q., Li, Q., Jiang, Y., Liu, Z., Zhong, L., Luo, R., Cheng, Q., & 青华 (2010) · Inflammation Research · doi:10.1007/s00011-010-0236-y · Cited by 15 · see citing works

Relationship between Fat Mass and Serum High-Sensitivity C-Reactive Protein Levels in Prevalent Hemodialysis Patients

Ishimura, E., Okuno, S., Tsuboniwa, N., Shoji, S., Yamakawa, T., Nishizawà, Y., & Inaba, M. (2011) · Nephron Clinical Practice · doi:10.1159/000328931 · Cited by 14 · see citing works

De novo Portal Vein Thrombosis in Non-Cirrhotic Non-Alcoholic Fatty Liver Disease: A 9-Year Prospective Cohort Study

Abdel‐Razik, A., Mousa, N., Shabana, W., Yassen, A. H., Abdelsalam, M., Wahba, M., Helmy, E. M., Tawfik, A. M., Zalata, K. R., Hasan, A. S., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.650818 · Cited by 14 · see citing works

Low‐grade inflammation can partly explain the association between the metabolic syndrome and either coronary artery disease or severity of peripheral arterial disease: the CODAM study

Jacobs, M., van Greevenbroek, M. M. J., Kallen, C., Ferreira, I., Blaak, E. E., Feskens, E. J. M., Jansen, E. H. J. M., Schalkwijk, C., & Stehouwer, C. D. A. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02129.x · Cited by 114 · see citing works

Effects of metabolic syndrome on lipid metabolism and inflammation factors in coronary heart disease

Li, X. (2010) · Hainan yixue

Low-Grade Chronic Inflammation in the Relationship between Insulin Sensitivity and Cardiovascular Disease (RISC) Population Associations with insulin resistance and cardiometabolic risk profile

de Rooij, S. R., Nijpels, M. G. A. A. M., Nilsson, P. M., Nolan, J. J., Gabriel, R., Bobbioni-Harsch, E., Mingrone, G., & Dekker, J. M. (2009) · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam)

Low-Grade Chronic Inflammation in the Relationship between Insulin Sensitivity and Cardiovascular Disease (RISC) Population

de Rooij, S. R., Nijpels, G., Nilsson, P. M., Nolan, J. J., Gabriel, R., Bobbioni-Harsch, E., Mingrone, G., Dekker, J. M., & for the Relationship Between Insulin Sensitivity and Cardiovascular Disease (RISC) Investigators (2009) · Diabetes Care · doi:10.2337/dc08-1795 · Cited by 109 · see citing works

[Correlation between atherosclerosis--coronary disease and insulin resistance, regarded as the basis of metabolic syndrome].

Mihalcea, C., & Pandele, G. I. (2010) · PubMed · Cited by 1 · see citing works